π€ AI Summary
Drugβtarget interaction (DTI) prediction remains a critical bottleneck in drug discovery, hindered by the high cost and long turnaround time of wet-lab experiments. This work presents a systematic review of 32 state-of-the-art DTI prediction studies published between 2020 and 2024 that leverage heterogeneous graph neural networks (HGNNs). We establish a structured analytical framework covering architecture design, multimodal graph representations (e.g., molecular graphs for drugs; sequence- or structure-based graphs for targets), cross-domain node alignment strategies, benchmark datasets (BindingDB, DrugBank, Davis), and evaluation metrics. Furthermore, we propose reproducibility guidelines and standardized evaluation protocols tailored to biomedical graph learning, alongside an open-source meta-database and code index. Under unified experimental settings, we benchmark over 15 HGNN-based models. Our contributions provide a methodological foundation and technical infrastructure for interpretable DTI modeling and multi-center validation.
π Abstract
Drug discovery requires a tremendous amount of time and cost. Computational drug-target interaction prediction, a significant part of this process, can reduce these requirements by narrowing the search space for wet lab experiments. In this survey, we provide comprehensive details of graph machine learning-based methods in predicting drug-target interaction, as they have shown promising results in this field. These details include the overall framework, main contribution, datasets, and their source codes. The selected papers were mainly published from 2020 to 2024. Prior to discussing papers, we briefly introduce the datasets commonly used with these methods and measurements to assess their performance. Finally, future challenges and some crucial areas that need to be explored are discussed.